Literature DB >> 23596033

'Broken Heart' syndrome in Scotland: a case of Takotsubo cardiomyopathy in a recently widowed lady.

A Mukherjee1, B Sünkel-Laing, N Dewhurst.   

Abstract

Takotsubo cardiomyopathy (TCM), first described in Japan in the early 1990s, is a reversible non-ischaemic cardiomyopathy of unclear aetiology characterised by transient left ventricular dysfunction. It mimics acute myocardial infarction with ST segment changes (STEMI), although evidence of occlusive coronary artery disease is absent. TCM is typically triggered by an intense physical or emotional stress event. We report a case of TCM diagnosed in a recently widowed lady in whom a myocardial infarction was initially suspected. This case illustrates the importance of an awareness of this unique clinical entity. Without appreciation of differentiating features, TCM can easily be misdiagnosed as an acute coronary syndrome. Misdiagnosis and the subsequent inappropriate and potentially harmful use of fibrinolytic therapy can be avoided through careful history-taking, clinical examination and appropriate investigations. Although well reported in the medical literature, this case of TCM provides the basis of a timely summary and update on current understanding of this perplexing condition.

Entities:  

Mesh:

Year:  2013        PMID: 23596033     DOI: 10.1177/0036933012474605

Source DB:  PubMed          Journal:  Scott Med J        ISSN: 0036-9330            Impact factor:   0.729


  3 in total

Review 1.  Takotsubo Syndrome - Stress-induced Heart Failure Syndrome.

Authors:  Mary N Sheppard
Journal:  Eur Cardiol       Date:  2015-12

2.  Takotsubo Syndrome Associated with ST Elevation Myocardial Infarction.

Authors:  Saad Ezad; Michael McGee; Andrew J Boyle
Journal:  Case Rep Cardiol       Date:  2019-05-16

3.  Clinical outcomes associated with catecholamine use in patients diagnosed with Takotsubo cardiomyopathy.

Authors:  Uzair Ansari; Ibrahim El-Battrawy; Christian Fastner; Michael Behnes; Katherine Sattler; Aydin Huseynov; Stefan Baumann; Erol Tülümen; Martin Borggrefe; Ibrahim Akin
Journal:  BMC Cardiovasc Disord       Date:  2018-03-20       Impact factor: 2.298

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.